hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 17:59:29 - browse：79771

Three Wegovy injection pens in a row — first opinion coverage from STAT — Adobe

Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments will change the amount of alcohol people drink.

This appears to be the first time the company is getting involved in research to see if the booming class of GLP-1 diabetes and obesity drugs can affect substance consumption, a question that academic researchers have been probing but the pharmaceutical industry has so far avoided.

The nine-month study will try three drugs alone and in combinations against placebo. The primary outcome being tested is change in liver scarring, or fibrosis, and one of the secondary outcomes is changes in alcohol consumption. The news of the study was first reported by Bloomberg.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

leisure time

WSS

What Henrietta Lacks's story taught me about my role as a doctor

What Henrietta Lacks's story taught me about my role as a doctor

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

4 missing after record

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

New requirements coming in 2024 for Americans traveling to Europe

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

What does generative AI mean for health care? We asked experts

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

FDA approval of Sarepta Duchenne genetic therapy gives me hope

PrEP can help anyone prevent HIV. Why do so few people take it?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Men with early prostate cancer can safely opt out of treatment

Cancer drug shortages should be causing more outrage

Thousands protest mob assault of women who were paraded naked in remote Indian border state

In Memoriam: Notable people who died in 2023

Doctors have an ethical obligation to be advocates

focus

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Obesity drug from Roche shows promise in early study

What a koala virus tells us about the human genome

Galapagos to make CAR

Doctors have an ethical obligation to be advocates

explore

leisure time

Wikipedia

Wikipedia